AMF Medical
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
Development of an insulin patch pump.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- FDA breakthrough designation
AMF Medical's Sigi Patch Pump, an ergonomic, rechargeable patch pump using pre-filled insulin cartridges, receives FDA breakthrough device designation while still under development.
- Acquisition announced
In December 2022, Tandem Diabetes Care announces plans to acquire AMF Medical SA, the privately held Swiss developer of the Sigi Patch Pump.
- Acquisition completed
On January 23, 2023, Tandem Diabetes Care completes the acquisition of AMF Medical; the AMF team and Sigi technology join Tandem's portfolio.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.